Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT04626245 |
Other study ID # |
1679889-1 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 13, 2022 |
Est. completion date |
June 30, 2027 |
Study information
Verified date |
October 2023 |
Source |
Lifespan |
Contact |
Margaret H Bublitz, PhD |
Phone |
4017937884 |
Email |
margaret_bublitz[@]brown.edu |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Hypertensive disorders of pregnancy (HDP) are the most common medical condition affecting
pregnancy and a leading cause of maternal morbidity and mortality in the Unites States. HDP
also increase lifetime cardiac disease risk in women and infants. Current interventions to
prevent HDP are limited, and interventions that do not include medications are minimally
effective at preventing HDP. Mindfulness interventions hold promise as a intervention to
prevent HDP that does not require pregnant women to take medications. Past research shows
that mindfulness interventions reduce blood pressure in adults with hypertension and
pre-hypertension. However, past studies of mindfulness interventions for pregnant women have
not allowed women at risk for HDP to participate. The preliminary study of prenatal
mindfulness training for women at risk for HDP demonstrated benefit on maternal blood
pressure and fetal growth. However, the mechanisms explaining effects of prenatal mindfulness
training on risk for HDP are unknown. Building upon these promising preliminary findings, the
proposed clinical trial will measure daily experiences of stress, physiological reactivity to
stress, and interpersonal processes before and after prenatal mindfulness training. The
investigators hypothesize that mindfulness training will impact these processes, which may
lead to improved maternal cardiovascular parameters and reduced risk for HDP. N=150 pregnant
women at risk for HDP will be randomized to an 8-week phone-delivered mindfulness
intervention or usual care. For every participant, we will measure maternal cardiovascular
parameters (24-hour blood pressure and uterine artery resistance values by ultrasound
Doppler) before and after the 8-week period. All participants will complete surveys of daily
experiences for 2 weeks before and after the 8-week period to evaluate mechanisms of
mindfulness training on maternal cardiovascular parameters. Daily experiences will be
measured using surveys delivered via smartphone-app, ambient audio sampling, and wearable
wrist-worn biosensor monitoring (heart rate and heart rate variability).
Description:
Hypertensive disorders of pregnancy (HDP) are the most common medical conditions in pregnancy
and a leading cause of maternal morbidity and mortality in the United States. HDP are also
associated with significant financial costs to the US healthcare system; $2.18 billion is
spent on treatment of affected mothers and infants in the first year after delivery. Women
exposed to HDP are at increased lifetime risk for cardiovascular disease, dementia, and
all-cause mortality. Current interventions to prevent HDP are limited and do not target
underlying mechanisms of disease. Mindfulness training (MT) holds tremendous promise as a
mind-body intervention to prevent HDP. MT is effective at reducing blood pressure in
non-pregnant patients with pre-hypertension and hypertension and has proven more effective at
blood pressure reduction than other stress management interventions. Results from the pilot
RCT were the first to indicate that prenatal phone-delivered MT is feasible and had a medium
to large effect on cardiovascular parameters in women at risk for HDP. However, the
mechanisms through which prenatal MT affects cardiovascular parameters are not yet
understood.
MT teaches participants to "attend and respond in a non-judgmental way to ordinary, everyday
experiences." Theory and available evidence indicate that MT elicits relaxation, decreases
stress biomarkers and autonomic activation, and decreases loneliness --- dynamic processes
that may serve as pathways to improved cardiovascular parameters in women at risk for HDP.
The proposed RCT will harness subjective and objective ecological momentary assessment (EMA)
methodologies (in vivo repeated assessments) in combination with wearable biosensor
technology to capture rich epochs of ecologically-valid psychological, physiological, and
interpersonal processes through which MT may lead to improved maternal cardiovascular
parameters. Pregnant women at risk for HDP will be randomized to an 8-week phone-delivered MT
intervention or usual care. For every participant, the research team will measure maternal
cardiovascular parameters (24-hour blood pressure and uterine artery resistance values by
ultrasound Doppler) before and after the RCT. All participants will complete EMA for 2 weeks
'bursts' before and after the RCT to evaluate mechanisms of MT on cardiovascular parameters.
EMA will include smartphone-app based experience sampling of psychological processes;
smartphone-app based ambient audio sampling (i.e. the Electronically Activated Recorder [EAR]
method) and wearable wrist-worn biosensor monitoring of physiological responses (heart rate
and heart rate variability) to everyday experiences. Results will provide new insights into
1) effects of MT on cardiovascular parameters in pregnancy, 2) pathophysiological mechanisms
of HDP, and 3) targets for new HDP prevention strategies.